Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Osteoporosis International

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00198-009-0973-3PMID 19484166
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

  2009cited by this paper
• Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.

  2009cited by this paper
• Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

  2008cited by this paper
• Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.

  2008cited by this paper
• Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity.

  2008cited by this paper
• Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker

  2008cited by this paper
• Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.

  2008cited by this paper
• Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.

  2008cited by this paper
• Oral bisphosphonates and dental implants: a retrospective study.

  2008cited by this paper
• Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.

  2008cited by this paper
• Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic

  2008cited by this paper
• Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

  2008cited by this paper
• Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: reply to Yarom and Elad

  2008cited by this paper
• Osteonecrosis of the Jaws and Bisphosphonate Therapy

  2007cited by this paper
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

  2007cited by this paper
• Oral bisphosphonate associated osteonecrosis of the jaws: three case reports

  2007cited by this paper
• Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women

  2007cited by this paper
• Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome

  2007cited by this paper
• Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle

  2007cited by this paper
• Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment.

  2007cited by this paper
• Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.

  2007cited by this paper
• Efficacy and safety of intravenous bisphosphonates in patients with bone metastases caused by metastatic breast cancer.

  2007cited by this paper
• A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.

  2007cited by this paper
• Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

  2007cited by this paper
• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

  2007cited by this paper
• The use of bisphosphonates in cancer patients

  2007cited by this paper
• Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report.

  2007cited by this paper
• Bisphosphonates and bisphosphonate induced osteonecrosis.

  2007cited by this paper
• Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.

  2007cited by this paper
• Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis.

  2007cited by this paper
• Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

  2006cited by this paper
• Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease

  2006cited by this paper
• Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.

  2006cited by this paper
• Osteonecrosis of the Mandible or Maxilla Associated with the use of New Generation Bisphosphonates

  2006cited by this paper
• Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women.

  2006cited by this paper
• Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations.

  2006cited by this paper
• Osteonecrosis of the jaw and oral bisphosphonate treatment.

  2006cited by this paper
• Efficacy and Tolerability of Alendronate Once Weekly in Asian Postmenopausal Osteoporotic Women

  2005cited by this paper
• Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

  2005cited by this paper
• The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study.

  2005cited by this paper
• Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review

  2004cited by this paper
• Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

  2004cited by this paper
• Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

  2003cited by this paper
• Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women.

  2002cited by this paper
• The Efficacy and Tolerability of Alendronate in Postmenopausal Osteoporotic Chinese Women: A Randomized Placebo-Controlled Study

  2000cited by this paper
• Skeletal Benefits of Two Years of Alendronate Treatment Are Similar for Early Postmenopausal Asian and Caucasian Women

  1999cited by this paper

• Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis

  2024cites this paper
• Recurrence - Related Factors of Medication Related Osteonecrosis of the Jaw (MRONJ) ; a Retrospective study

  2023cites this paper
• Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons

  2021cites this paper
• The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review

  2021cites this paper
• A gyógyszer okozta állcsontnekrózis prognózisát befolyásoló faktorok Prognostic factors of the medication-related osteonecrosis of the jaw

  2020cites this paper
• Effects of anti-resorptive drugs on implant survival and peri-implantitis in patients with existing osseointegrated dental implants: a retrospective cohort study

  2020cites this paper
• Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw

  2020cites this paper
• The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial☆

  2019cites this paper
• Impact of bisphosphonate therapy on dental implant outcomes: An overview of systematic review evidence.

  2019cites this paper
• Biphosphonate-Related Osteonecrosis (BRONJ) in Cancer Patients: Retrospective Study

  2018cites this paper
• Subclinical Oral Bisphosphonate-related Osteonecrosis of the Jaw: Systematic Review of the Literature and an Additional Case

  2017cites this paper
• Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw

  2017cites this paper
• What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.

  2017cites this paper
• Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis

  2017cites this paper
• Dental Implants in Osteoporotic Patients Taking Oral Bisphophonates: A Literature Review

  2017cites this paper
• What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis.

  2016cites this paper
• Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study

  2016influential citation
• BRONJ in patients with rheumatoid arthritis: a multicenter case series.

  2016cites this paper
• 15-03-16 ( 2 ) 1 BRONJ IN PATIENTS WITH RHEUMATOID ARTHRITIS : A MULTICENTRE CASE SERIES

  2016cites this paper
• Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons

  2015cites this paper
• Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.

  2015influential citation
• A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis

  2015cites this paper
• Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis.

  2015cites this paper
• A case of early detection of bisphosphonate-related osteonecrosis of the jaw

  2015cites this paper
• Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants.

  2015cites this paper
• Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report.

  2014cites this paper
• Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: two cases and review of the literature.

  2014cites this paper
• BISPHOSPHONATES IN DENTISTRY AN ASIAN PERSPECTIVE – EVIDENCE BASED REVIEW -

  2014cites this paper
• Methotrexate-associated lymphoproliferative disorder complicated by bisphosphonate-related osteonecrosis of the jaw arising in a female rheumatoid arthritis patient: Report of a case

  2014cites this paper
• Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review.

  2013influential citation
• Osteonecrosis of the Jaw and Rheumatoid Arthritis. Is It the Disease or the Drugs?

  2013cites this paper
• Osteonecrosis of the Jaw and Nonmalignant Disease: Is There an Association with Rheumatoid Arthritis?

  2013cites this paper
• Bisphosphonates and Dental Implant Treatment

  2013cites this paper
• Tooth extraction in osteoporotic patients taking oral bisphosphonates

  2013cites this paper
• Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: A systematic review.

  2012influential citation
• Characteristics of Bisphosphonate-Related Osteonecrosis of the Jaw After Kidney Transplantation

  2012cites this paper
• Myositis Ossificans Traumatica of the Masticatory Muscles

  2012cites this paper
• Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.

  2012cites this paper
• Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws

  2012influential citation
• Effect of alendronate on healing of extraction sockets and healing around implants.

  2011cites this paper
• INFLUÊNCIA DO DIABETES E DA CORTICOTERAPIA NO DESENVOLVIMENTO DA OSTEONECROSE MAXILAR ASSOCIADA AO USO DE ALENDRONATO DE SÓDIO INFLUENCE OF DIABETES AND CORTICOTHERAPY IN THE DEVELOPMENT OF OSTEONECROSIS OF THE JAWS ASSOCIATED WITH SODIUM ALENDRONATE

  2011cites this paper
• Is rheumatoid arthritis a risk factor for oral bisphosphonate-induced osteonecrosis of the jaws?

  2011cites this paper
• A rational approach to dental management of patients on bisphosphonates.

  2011cites this paper
• Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports

  2011influential citation
• Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.

  2010cites this paper
• Effect of Alendronate on Healing of Extraction Sockets and Osseointegration of Implants in the Maxilla of Rats : Histologic Analysis

  2010cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2010cites this paper
• La chirurgia orale in pazienti che assumono bisfosfonati per via endovenosa: analisi della letteratura e caso clinico

  2010cites this paper
• Osteonecrosis of the jaw in patients receiving oral bisphosphonates

  2010influential citation